Publications by authors named "Lucija Lulic"

Head and neck cancers rank as the sixth most prevalent cancers globally. In addition to traditional risk factors such as smoking and alcohol use, human papillomavirus (HPV) infections are becoming a significant causative agent of head and neck cancers, particularly among Western populations. Although HPV offers a significant survival benefit, the search for better biomarkers is still ongoing.

View Article and Find Full Text PDF
Article Synopsis
  • Infection with HPV type 16 is linked to a specific type of oropharyngeal cancer (OPSCC) that differs significantly in characteristics from HPV-negative OPSCCs.
  • Research has focused on the NHERF2 protein, which is degraded by the HPV16 E6 oncoprotein, leading to increased cancer cell growth, but no specific biomarkers or therapies have been established yet.
  • Analysis of tissue samples showed notably lower NHERF2 levels in HPV16-positive OPSCCs and poorly differentiated HPV-negative tumors, highlighting the role of E6's interaction with NHERF2 in HPV-related cancer development in the head and neck.
View Article and Find Full Text PDF

Human papillomaviruses (HPVs), which are small, double-stranded, circular DNA viruses infecting human epithelial cells, are associated with various benign and malignant lesions of mucosa and skin. Intensive research on the oncogenic potential of HPVs started in the 1970s and spread across Europe, including Croatia, and worldwide. Nowadays, the causative role of a subset of oncogenic or high-risk (HR) HPV types, led by HPV-16 and HPV-18, of different anogenital and head and neck cancers is well accepted.

View Article and Find Full Text PDF

The major causative agents of head and neck squamous cell carcinomas (HNSCCs) are either environmental factors, such as tobacco and alcohol consumption, or infection with oncogenic human papillomaviruses (HPVs). An important aspect of HPV-induced oncogenesis is the targeting by the E6 oncoprotein of PDZ domain-containing substrates for proteasomal destruction. Tumor suppressors DLG1 and SCRIB are two of the principal PDZ domain-containing E6 targets.

View Article and Find Full Text PDF

Human papillomavirus (HPV) E6 and E7 oncoproteins are critical for development and maintenance of the malignant phenotype in HPV-induced cancers. These two viral oncoproteins interfere with a plethora of cellular pathways, including the regulation of cell cycle and the control of apoptosis, which are critical in maintaining normal cellular functions. E6 and E7 bind directly with certain components of the Ubiquitin Proteasome System (UPS), enabling them to manipulate a number of important cellular pathways.

View Article and Find Full Text PDF